financetom
Business
financetom
/
Business
/
General Motors Shares Are Rising Today: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Motors Shares Are Rising Today: What's Going On?
Jan 23, 2025 1:05 PM

General Motors Co. ( GM ) shares are trading higher Thursday on reports the company and Hyundai are forging an EV partnership for North America.

What To Know: Hyundai has confirmed ongoing talks to supply commercial electric vehicles to GM as part of a broader collaboration that includes parts procurement and passenger vehicle cooperation, according to Reuters. The companies reportedly aim to finalize binding agreements by the end of the first quarter of 2025.

“We are considering re-badging our commercial EVs and supplying GM… The deal will pave the way for our entry into the North American commercial vehicle market,” Hyundai CFO Lee Seung Jo reportedly said on an analyst call.

The planned partnership comes as both automakers navigate uncertainties in U.S. trade policy under U.S. President Donald Trump, who has proposed potential tariffs on imports from Canada and Mexico starting Feb. 1.

Separately, GM announced a recall of 2,890 all-wheel-drive Chevrolet Equinox EVs from the 2025 model year this week due to a software calibration issue in the brake control module.

The malfunction affects the adaptive cruise control feature, preventing the vehicle from braking as designed, which increases the risk of crashes. GM dealerships will address the issue by updating the software to restore proper functionality.

The Equinox EV, introduced in 2024, accounted for 41% of GM's electric vehicle sales in the fourth quarter, with 18,089 units delivered during the period. It was the 8th best-selling EV in the U.S. last year, with 28,874 units sold.

GM Price Action: General Motors ( GM ) shares were up 2.49% at $54.07 at the time of publication, according to Benzinga Pro.

Read Next:

Wall Street Eyes Intuitive Surgical Q4 Earnings As Stock Hits New Heights

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Seyond Strengthens Commercial Momentum and Market Presence Following IPO
Seyond Strengthens Commercial Momentum and Market Presence Following IPO
Mar 10, 2026
SUNNYVALE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Following its successful listing on the Main Board of the Hong Kong Stock Exchange (02665.HK), Seyond, a global leader in image-grade LiDAR solutions, is entering a new phase of growth marked by accelerating commercial traction and expanding adoption across autonomous mobility markets. With a mission to connect the digital and physical worlds...
Cytokinetics Insider Sold Shares Worth $1,322,800, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $1,322,800, According to a Recent SEC Filing
Mar 10, 2026
04:17 PM EST, 12/23/2025 (MT Newswires) -- Wendell Wierenga, Director, on December 22, 2025, sold 20,000 shares in Cytokinetics ( CYTK ) for $1,322,800. Following the Form 4 filing with the SEC, Wierenga has control over a total of 32,444 common shares of the company, with 32,444 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198325000051/xslF345X05/form4.xml ...
Potlatchdeltic Insider Sold Shares Worth $948,758, According to a Recent SEC Filing
Potlatchdeltic Insider Sold Shares Worth $948,758, According to a Recent SEC Filing
Mar 10, 2026
04:22 PM EST, 12/23/2025 (MT Newswires) -- Eric J Cremers, Director, President and CEO, on December 19, 2025, sold 24,123 shares in Potlatchdeltic ( PCH ) for $948,758. Following the Form 4 filing with the SEC, Cremers has control over a total of 296,043 common shares of the company, with 296,043 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1338749/000119312525330922/xslF345X05/ownership.xml ...
Solventum Closes Acquisition of Acera Surgical
Solventum Closes Acquisition of Acera Surgical
Mar 10, 2026
04:21 PM EST, 12/23/2025 (MT Newswires) -- Solventum ( SOLV ) said late Tuesday it closed the acquisition of Acera Surgical for $725 million in upfront cash with provisions for up to $125 million in milestone-based payments. The addition of Acera's synthetic tissue matrix technology will expand Solventum's ( SOLV ) wound care portfolio, the company said. The transaction is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved